Indefinite Delivery Contract 36E79726D0010
Award Date 3/15/26
Last Date to Order 3/14/27
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- This indefinite delivery contract was awarded by the VA National Acquisition Center, a civilian federal agency, to Seqirus USA Inc., a foreign-owned, for-profit biotechnology company that specializes in the development, manufacturing, and delivery of influenza vaccines. The contract has a ceiling value of $51,637,946.01 and a period of performance from March 15, 2025 to March 14, 2026. The contract is for the supply of influenza virus vaccines to the VA, State Veteran Homes, Bureau of Prisons,...
- The Department of Veterans Affairs National Acquisition Center awarded an indefinite delivery contract to Seqirus USA Inc. to deliver influenza virus vaccines for the 2022-2023 season to the VA, Federal Bureau of Prisons, Indian Health Service, and James A. Lovell Federal Health Care Center. Task orders under the contract, with a potential value of $69,190,924.13, provide vaccines including 10-dose vials, single dose syringes in boxes of 10, and an adjuvant vaccine for individuals aged 65 and...
- Seqirus USA Inc. has been awarded a multiple-award Federal Supply Schedule contract under the Pharmaceuticals and Drugs (FSS-61-IB) classification by Veterans Integrated Service Network 12, a civilian agency within the Department of Veterans Affairs. The contract, effective September 1, 2024, through August 31, 2029, carries a ceiling value of $2,555,130.00 and supports the procurement of drugs, pharmaceuticals, and hematology-related products with a specific focus on influenza vaccines. The...
- Seqirus USA Inc., a global biotechnology company, has been awarded a multiple-award Federal Supply Schedule (FSS) contract V797D70074 by the U.S. Department of Veterans Affairs (VA) to provide a range of influenza vaccines and pharmaceuticals. The contract, which is set under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, enables Seqirus to deliver a variety of influenza vaccine formulations and presentations, including multi-dose vials, pre-filled syringes, and specialized vaccines for...
- This single-award Indefinite Delivery Contract, issued by the Department of Veterans Affairs National Acquisition Center on March 15, 2026, procures Influenza Virus Vaccine for the 2026-2027 influenza season from Sanofi Pasteur Inc., a pharmaceutical manufacturer specializing in vaccine production. The contract carries a ceiling value of $8.67 million and extends through March 14, 2027. The procurement serves multiple federal agencies including the Department of Veterans Affairs, State Veteran...
- Sanofi Pasteur Inc., a foreign-owned pharmaceutical manufacturer specializing in vaccine production, was awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs' National Acquisition Center (acting as the Civilian Funding Agency) on March 15, 2025, with a ceiling value of $113,670.50 and a performance period extending through March 14, 2026. This contract procures Influenza Virus Vaccine for the 2025-2026 flu season and incorporates a 2026 Small Business...
- The Defense Logistics Agency Troop Support Medical awarded a single-award Indefinite Delivery Contract to Seqirus USA Inc. with a potential value of $12,954,518.10 to supply influenza virus vaccinations. Under this contract, three firm fixed price delivery orders have been issued to Seqirus USA Inc. totaling $12,710,418.40 to provide influenza virus vaccinations for the 2022-2023 flu season. The delivery orders require vaccinations be delivered to Summit, New Jersey by August 31, 2022. The...
- Seqirus USA Inc. (UEI: N6U7P2B9VHS5) was awarded a multiple-award Indefinite Delivery Contract with a ceiling value of $86.5 million by the Centers for Disease Control and Prevention (CDC) to supply adult influenza vaccines through February 28, 2027. This civilian procurement, awarded December 31, 2025, supports the CDC's vaccine distribution requirements without utilization of small business set-asides. The contract represents Seqirus's established position as a critical federal vaccine...
- The federal contract IDV award is for the procurement of influenza virus vaccines for the 2024-2025 flu season. The prime contractor is Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of pharmaceutical goods. This award is being made by the U.S. Department of Veterans Affairs (VA) National Acquisition Center and will be used to supply vaccines to the VA, State Veteran Homes, Bureau of Prisons, Indian Health Service, and Captain James A. Lovell Federal Health Care Center. The...
- This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency's Medical Supply Chain unit to Seqirus USA Inc., a global biotechnology company specializing in influenza vaccine development and delivery. The contract, valued at $36,120,112.50, aims to procure approximately 3.23 million doses of injectable influenza virus vaccines in multi-dose vials and pre-filled syringes for various age groups, including elderly, adult, and pediatric populations. The vaccines are intended...